These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 34787449
21. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. JAMA; 2008 Jan 09; 299(2):173-84. PubMed ID: 18182599 [Abstract] [Full Text] [Related]
23. Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses - results from two phase 2b randomized trials in adolescents. Vesikari T, Brzostek J, Ahonen A, Paassilta M, Majda-Stanislawska E, Szenborn L, Virta M, Clifford R, Jackowska T, Kimmel M, Bindi I, Keshavan P, Pedotti P, Toneatto D. Hum Vaccin Immunother; 2021 Nov 02; 17(11):4689-4700. PubMed ID: 34582323 [Abstract] [Full Text] [Related]
24. Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers. Findlow J, Bai X, Findlow H, Newton E, Kaczmarski E, Miller E, Borrow R. Vaccine; 2015 Jun 26; 33(29):3322-30. PubMed ID: 26025807 [Abstract] [Full Text] [Related]
28. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults. Alberer M, Burchard G, Jelinek T, Reisinger E, Beran J, Hlavata LC, Forleo-Neto E, Dagnew AF, Arora AK. J Travel Med; 2015 Jun 26; 22(1):48-56. PubMed ID: 25308927 [Abstract] [Full Text] [Related]
38. Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults. Alberer M, Burchard G, Jelinek T, Reisinger EC, Meyer S, Forleo-Neto E, Dagnew AF, Arora AK. J Travel Med; 2015 Dec 26; 22(2):105-14. PubMed ID: 25483566 [Abstract] [Full Text] [Related]
39. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. Flacco ME, Manzoli L, Rosso A, Marzuillo C, Bergamini M, Stefanati A, Cultrera R, Villari P, Ricciardi W, Ioannidis JPA, Contopoulos-Ioannidis DG. Lancet Infect Dis; 2018 Apr 26; 18(4):461-472. PubMed ID: 29371070 [Abstract] [Full Text] [Related]
40. Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. Borja-Tabora CF, Montalban C, Memish ZA, Boutriau D, Kolhe D, Miller JM, Van der Wielen M. BMC Infect Dis; 2015 Oct 06; 15():409. PubMed ID: 26437712 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]